Challenging Cases in Colposcopy and Cervical Cancer Screening
This course will use challenging cases to help participants better manage patients within the frameworks of recent national recommendations published by ASCCP and other professional organizations. These include the ASCCP/ACS/ASCP Screening Guidelines for the Prevention and Early Detection of Cervical Cancer, the ASCCP Guidelines for the Management of Abnormal Screening Tests and Cancer Precursors, the ASCCP/SGO Interim Guidance on the Clinical Use of Primary HPV Testing for Cervical Cancer Screening, and the ASCCP/CAP Lower Anogenital Squamous Terminology. The challenging cases presented and faculty discussion will not only help participants to understand how to use the various guidelines in common clinical situations, but will also explore acceptable management scenarios in situations for which the guidelines and algorithms may not apply. While these five guidelines have been in clinical use for several years now, they are not without controversy. Some of the controversial aspects of these guidelines will be explored by the course faculty. After attending this postgraduate course, attendees will have a better understanding of the rationale for the recommendations, and opportunities to apply these guidelines in various common, and uncommon, specific cases and patient populations.
- Apply an understanding of the epidemiology and natural history of HPV and cervical cancer precursors to the rational screening of women for cervical cancer using the current consensus guidelines and interim guidance for use of primary HPV testing for cervical cancer screening;
- Apply the basic and clinical science underlying the Updated Consensus Management Guidelines to the individualized management of abnormal screening tests and pre-invasive histologic lesions;
- Manage women from special populations (e.g., adolescent, postmenopausal, and pregnant women) with abnormal screening results and CIN/AIS; and
- Interpret biopsy results that use the LAST terminology LSIL/HSIL rather than CIN1, CIN2, CIN3.
Continuing Medical Education (CME)
ASCCP is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.
AMA PRA Category 1 Credit(s)TM
ASCCP designates this live activity for a maximum of 3.75 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
All those who have an opportunity to control content (Faculty, Program Directors, Reviewers, Staff, etc), are required to complete a COI based on the following instructions:
ASCCP members and the general public place great trust in the work of the Society. Real or perceived undisclosed conflicts of interest may jeopardize that trust and ASCCP’s effectiveness. Conflicts of interest also may affect the objectivity of decisions that ASCCP officers and volunteers make. To minimize the potential impact of possible conflicts of interest, the Board of Directors has determined that all participants in ASCCP activities must report all real or potential conflicts prior to the activity being developed and delivered to the learners. All disclosure forms are reviewed by the Course Director of each activity. Course Director disclosure forms are reviewed by ASCCP’s Education Committee. Most conflicts involve financial relationships with commercial interests. A commercial interest is defined as any entity producing, marketing, re-selling, or distributing health care goods or services consumed by, or used on, patients. These may include pharmaceutical companies, device manufacturers or distributors, service companies, or other for-profit entities. Relationships with commercial interests may affect how officers or volunteers view products or services. They may also prompt outsiders to assume bias even when none exists, harming the reputation and effectiveness of the Society. Specific relationships with potential to create conflict of interest can include direct employment, management positions including directors and officers, royalties, consultants or board or advisory board positions, lecture fees paid by an entity (including membership on speakers bureaus or review panels), expert testimony especially to regulatory bodies or in litigation, ownership or beneficial ownership of stock or stock options, research funding, honoraria, gifts including travel or other in-kind payments (e.g., accommodations, sports tickets, appliances, electronic devices, etc.), intellectual property rights received or pending, and participation in sponsored research as a principal investigator. Contracted research funded by a commercial source also creates a potential conflict of interest; this includes research funding by which an employing institution receives a grant and manages funds and the CME provider serves as principal or named investigator on the grant. Investments made through diversified mutual funds or blind trusts in which the participant does not exercise decisional control are excluded. Usually primary employment by a nonprofit or governmental organization does not create potential for conflict, but compensation to employers based on an individual’s work with a for-profit company may create bias that must be reported. Income from commercial entities unrelated to health care does not create a potential for conflict of interest. By disclosing all relationships, participants and the Society allow others to judge the extent to which conflicts may have affected judgments in conscious or unconscious ways. If the potential for any relationship to create conflict of interest appears doubtful, then it should be disclosed.